Tag: R&D

Research and development (R&D or R+D), also known in Europe as research and technical (or technological) development (RTD), is a general term for activities in connection with corporate or governmental innovation. Research and development is situated at the front end of the innovation life cycle, which may end with commercialization.

Ascletis Pharma Announced Opening of Clinical Development Center in Shanghai

r&d
Ascletis Pharma Inc, an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, ann...

Teva Established North America R&D Campus

Teva Pharmaceuticals USA, Inc. announced that the company has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pa., which, together with three other buildings Teva owns...

Pharma Invests £377m in UK R&D Collaborations, New ABPI Figures Showed

New figures published by the ABPI show that pharma invests £377m in UK R&D collaborations, working with healthcare professionals and organisations to improve care for NHS patients. The data pub...

EMA to Review MAA for First China-Developed Trastuzumab Biosimilar

First trastuzumab developed in China following the National Medical Products Administration (NMPA) technical guideline for biosimilar with the New Drug Application (NDA) received the acceptance for re...

PeptiDream and Novartis in New Collaboration

Japanese biotech PeptiDream has announced a new peptide drug conjugate (PDC) collaboration with Swiss pharma major Novartis. PeptiDream will use its proprietary Peptide Discovery Platform System te...

Chinese Plan on Generics Production

The list, which includes drugs that treat serious diseases such as AIDS and leukemia, has been published on the commission's website and is soliciting public opinion for five working days. The Nati...

Global Biopharm AstraZeneca to Invest $630m over 5 years in Korean R&D

astrazeneca
AstraZeneca PLC, a British-Swedish pharmaceutical company, will invest a total $630 million in South Korea’s biotech and healthcare sectors over five years starting next year, betting on the Korean go...

GC Pharma Established Cell Therapy Development Company

GC Pharma and affiliate GC LabCell said Thursday they have jointly established a cell therapy development company called Artiva Biotherapeutics. Artiva Biotherapeutics was launched in March in San ...

Bristol-Myers Announced New R&D Team

bristol-myers squibb
Bristol-Myers Squibb has unveiled the new-look team that will lead its R&D group after the closure of its Celgene takeover. The Big Pharma is dividing the group up into early- and late-phase d...

Top 15 Largest Pharma Companies Funneled more than $100b into R&D in 2018

Big Pharma companies are still, naturally, the big spenders in drug R&D, and the numbers are impressive: last year, and for the first time, the top 15 largest companies (by sales) funneled more th...

Pfizer Opened New R&D Facility in Missouri

Building on our 17-year history in Missouri, a newly opened, state-of-the-art, 295,000 square feet facility in Chesterfield will expand the capacity of colleagues dedicated to the research and develop...

Medicines Australia Welcomes R&D Tax Reform

lab
Medicines Australia welcomes announcement from the Australian Labor Party to reform the Research and Development (R&D) Tax Incentive if elected on 18 May. Medicines Australia CEO Ms Liz de Some...

Armenia Partners with WHISE-Embleema in Digital Healthcare

The Government of the Republic of Armenia, announced a partnership with the WHISE-Embleema Consortium, an organization whose mission is to accelerate the research and development of innovative new med...

Roche and Novartis are Among the Biggest Spenders on R&D in 2018

Over the past decade Roche and Novartis consistently spent more on R&D than other big pharma groups, evaluate.com reports. Abbvie and Astrazeneca have added to their budgets. The world’s 12 big...

Ono Pharmaceutical and twoXAR in R&D Collaboration

Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, announced today that the c...

Servier and Oncodesign Team Up for R&D Parkinson’s Drug

Servier, an international pharmaceutical company governed by a non-profit foundation, and biopharmaceutical company, Oncodesign have announced a strategic partnership for the research and development ...